EP3488443
NÝVAKAEININGAR VALDAR SEM SJÚKDÓMSSÉRTÆKT MARKMIÐ TIL MEÐFERÐAR MEÐ BÆTTRI SKILVIRKNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.7.2017EP published:
18.8.2021EP application number:
17743311.7
EP translation filed:
20.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
18.7.2037Expiry date:
18.7.2026Next due date:
31.7.2026
Title:
SELECTING NEOEPITOPES AS DISEASE-SPECIFIC TARGETS FOR THERAPY WITH ENHANCED EFFICACY
Timeline
Today
19.7.2017EP application
18.8.2021EP Publication
20.9.2021Translation submitted
15.10.2021Registration published
18.7.2026Expires
Owner
Name:
BioNTech SEAddress:
An der Goldgrube 12, 55131 Mainz, DE
Inventor
Name:
TADMOR, Arbel D.Address:
55294 Bodenheim, DE
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2016/067348Date:
20.7.2016Country:
WO
Classification
Categories:
C12N 15/10
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.7.2022
Expires: 18.7.2023
Payer: Patice ehf.
Number: 7
Paid: 22.6.2023
Expires: 18.7.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.6.2024
Expires: 18.7.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.7.2025
Expires: 18.7.2026
Payer: Árnason Faktor ehf.